Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRIAN MICHAEL LINGERFELT

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1942418744
CMS profile
269340
Location
CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,113.60

106 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,089.42 104
Education $24.18 2

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRIAN MICHAEL LINGERFELT

NPI 1942418744 · CMS profile ID 269340

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1942418744?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1942418744?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1942418744?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1942418744?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

106 matching records · $2,113.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 106 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 106.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Mylan Institutional Inc. $11.6307/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965336141 CMS
Janssen Biotech, Inc. $16.6307/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788847283 CMS
Merck Sharp & Dohme Corporation $15.6507/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848464113 CMS
Mylan Institutional Inc. $14.0607/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965336101 CMS
Gilead Sciences, Inc. $21.9606/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848231127 CMS
JAZZ PHARMACEUTICALS INC. $18.5306/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845629767 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.4506/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763579704 CMS
Takeda Pharmaceuticals U.S.A., Inc. $32.3506/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820051281 CMS
Janssen Biotech, Inc. $18.5706/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788847287 CMS
PFIZER INC. $18.5706/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832731313 CMS
GlaxoSmithKline, LLC. $17.2006/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802961929 CMS
Merck Sharp & Dohme Corporation $16.5906/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848424113 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845875793 CMS
Dova Pharmaceuticals $20.9805/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849748085 CMS
Incyte Corporation $21.3905/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835553125 CMS
E.R. Squibb & Sons, L.L.C. $11.1105/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783664165 CMS
AstraZeneca Pharmaceuticals LP $20.8305/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829708455 CMS
Seagen Inc. $14.0805/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832172411 CMS
AstraZeneca Pharmaceuticals LP $15.2805/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829505627 CMS
AstraZeneca Pharmaceuticals LP $12.6505/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829427587 CMS
Eisai Inc. $21.8804/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817924851 CMS
Secura Bio, Inc. $12.0604/23/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 851660151 CMS
AstraZeneca Pharmaceuticals LP $16.7904/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829605569 CMS
E.R. Squibb & Sons, L.L.C. $15.3504/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783664155 CMS
Regeneron Healthcare Solutions, Inc. $11.3804/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809599773 CMS
Secura Bio, Inc. $12.2604/13/2021 Education No dispute reported Delay: No
Change: CHANGED
06/30/2026 851660147 CMS
Daiichi Sankyo Inc. $14.4304/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836281635 CMS
E.R. Squibb & Sons, L.L.C. $26.4603/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783664147 CMS
Janssen Biotech, Inc. $12.3203/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788847291 CMS
BeiGene USA, Inc. $17.3703/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846699169 CMS
Regeneron Healthcare Solutions, Inc. $12.5103/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809599771 CMS
Amgen Inc. $22.5703/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826305501 CMS
Acceleron Pharma, Inc. $15.0003/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843320633 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.2403/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763579706 CMS
Eisai Inc. $11.2003/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818053289 CMS
Merck Sharp & Dohme Corporation $23.8002/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848430727 CMS
Amgen Inc. $20.3302/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825191729 CMS
Janssen Biotech, Inc. $14.3802/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788847295 CMS
GENZYME CORPORATION $23.8202/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843616187 CMS
Rigel Pharmaceuticals, Inc. $17.1902/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854324987 CMS
Celgene Corporation $14.7502/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783733247 CMS
GlaxoSmithKline, LLC. $20.5502/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802313605 CMS
Foundation Medicine, Inc. $174.7202/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 799851681 CMS
E.R. Squibb & Sons, L.L.C. $15.8602/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783664131 CMS
Genentech USA, Inc. $19.5902/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835893703 CMS
GENZYME CORPORATION $16.5002/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843616181 CMS
Merck Sharp & Dohme Corporation $18.3301/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848598165 CMS
Astellas Pharma US Inc $19.9001/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821423529 CMS
AbbVie Inc. $15.7601/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795345929 CMS
Merck Sharp & Dohme Corporation $18.6101/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848464231 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,175.57 116
PY2020 $1,732.91 89
PY2021 $2,113.60 106
PY2022 $2,554.88 126
PY2023 $2,491.00 115
PY2024 $2,009.19 95
PY2025 $2,214.78 89

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,828.50 7
PY2024 Principal investigator $11,255.88 6
PY2023 Principal investigator $22,465.15 8
PY2022 Principal investigator $57,202.74 18
PY2021 Recipient $2,576.00 1
PY2021 Principal investigator $188,562.75 29
PY2020 Principal investigator $426,518.06 44
PY2019 Recipient $10,385.00 3
PY2019 Principal investigator $337,286.94 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $411.00 09/04/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738153
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,500.00 09/04/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738155
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $68.00 05/28/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738149
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $56.00 05/28/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738151
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $278.00 05/02/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738147
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $223.00 02/20/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738145
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $10,292.50 02/06/2025 Non-covered Recipient Entity
Rsfpp Orthopedic Charleston Hand Group
Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies No dispute reported 06/30/2026 1235994135